MamaLift Plus
by Curio Digital Therapeutics, Inc.
MamaLift Plus is a mental health/function therapeutic software (FDA Class II; FDA product code SAP, Computerized Behavioral Therapy Device For Depressive Disorders.) made by Curio Digital Therapeutics, Inc., cleared under FDA 510(k) K223515 on 22 Apr 2024 and listed in FDA GUDID since 19 Feb 2025 (UDI-DI 00860012970308), active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00860012970308 | Date19 Feb 2025 | StatusListed |
| United States | FDA 510(k)SESE | NumberK223515 | Date22 Apr 2024 | StatusActive |
Official records
- AccessGUDID record 00860012970308
- FDA 510(k) database K223515
From the FDA record
- Device description
- MamaLift Plus is a digital therapy designed to treat symptoms of postpartum depression by delivering evidence-based therapeutic components of Cognitive Behavioral Therapy via software on a mobile application, such as a smartphone or tablet.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K223515 decided 22 Apr 2024 Active
- FDA GUDID UDI-DI 00860012970308 listed 19 Feb 2025 Listed
Timeline
- Cleared FDA 510(k) K223515
- Listed FDA GUDID 00860012970308
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Generic name
- Mental health/function therapeutic software, screen-viewed
- Model / reference
- MamaLift Plus
- Primary DI / UDI-DI
- 00860012970308
- 510(k) Number
- FDA product code
- SAP
- GMDN term
- Mental health/function therapeutic software, screen-viewed
- Device class
- Class II
- Regulation number
- 882.5801
- GUDID distribution status
- In Commercial Distribution